VEA
ARCT icon

Virtus ETF Advisers’s Arcturus Therapeutics ARCT Stock Holding History

Virtus ETF Advisers’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,051
Closed -$68.7K – 448
2024
Q4 		$68.7K Buy
4,051
+1,132
+39% +$21.3K 0.03% 388
2024
Q3 		$67.8K Buy
2,919
+54
+2% +$1.16K 0.03% 430
2024
Q2 		$69.8K Sell
2,865
-222
-7% -$6.73K 0.03% 431
2024
Q1 		$104K Sell
3,087
-215
-7% -$7.62K 0.06% 356
2023
Q4 		$104K Sell
3,302
-280
-8% -$6.66K 0.07% 345
2023
Q3 		$91.5K Sell
3,582
-354
-9% -$10.9K 0.06% 345
2023
Q2 		$113K Sell
3,936
-1,431
-27% -$39K 0.07% 338
2023
Q1 		$129K Sell
5,367
-2,064
-28% -$37K 0.07% 324
2022
Q4 		$126K Sell
7,431
-661
-8% -$11.5K 0.07% 402
2022
Q3 		$120K Buy
8,092
+53
+0.7% +$889 0.05% 398
2022
Q2 		$127K Buy
8,039
+3,507
+77% +$68.8K 0.05% 363
2022
Q1 		$122K Sell
4,532
-271
-6% -$6.92K 0.05% 264
2021
Q4 		$178K Sell
4,803
-1,110
-19% -$45.2K 0.07% 253
2021
Q3 		$283K Sell
5,913
-316
-5% -$14.2K 0.12% 206
2021
Q2 		$211K Buy
6,229
+3,444
+124% +$117K 0.09% 307
2021
Q1 		$115K Buy
2,785
+42
+2% +$2.5K 0.05% 349
2020
Q4 		$119K Buy
+2,743
New +$186K 0.05% 350

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Virtus ETF Advisers's ARCT Position: Q1 2025 in Review

Virtus ETF Advisers sold out of Arcturus Therapeutics (ARCT) in Q1 2025, closing a stake of 4,051 shares — an estimated $68.7K sold.

Virtus ETF Advisers first reported a position in ARCT in Q4 2020 and held it in 17 quarters. The position peaked at $283K in Q3 2021. 144 funds tracked by Wall St. Rank hold ARCT as of Q1 2025.

  • Virtus ETF Advisers reported no remaining Arcturus Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Virtus ETF Advisers sold 4,051 Arcturus Therapeutics shares in Q1 2025, an estimated $68.7K.
  • Virtus ETF Advisers first reported a position in Arcturus Therapeutics in Q4 2020 and held it in 17 quarters.
  • Virtus ETF Advisers's Arcturus Therapeutics position peaked at $283K in Q3 2021.
  • 144 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q1 2025.

Based on Virtus ETF Advisers's 13F filing for Q1 2025, filed 14 May 2025.